Navigation Links
Business Guru Michael E. Gerber appointed to ReliantHeart Board of Directors
Date:11/21/2013

HOUSTON, TX (PRWEB) November 21, 2013

ReliantHeart, Inc., the manufacturer of the HeartAssist5® Ventricular Assist Device (VAD) has appointed to its Board of Directors Michael E. Gerber, writer of the best-selling book 'The E-Myth Revisited' and well-known legend of entrepreneurship.

INC. Magazine called Gerber “the World’s #1 Business Guru,” with his 40 years of experience addressing the needs of businesses owned primarily by people with technical skills but few business skills, and no place to go to get meaningful help. Over the years, Gerber’s companies have helped tens of thousands of business owners successfully transform their businesses into world-class operations.

Gerber created The Dreaming Room®, a training program that is held throughout the United States, Canada and the United Kingdom. Based on his experiences with entrepreneurs in these Dreaming Room events, along with the tens of thousands of clients Gerber has done business coaching with over the years, he authored 'Awakening the Entrepreneur Within.'

Gerber is also the best-selling author of 'The E-Myth Revisited,' co-authored several E-Myth industry-specific books, and 13 other business coaching books. The 'E-Myth Revisited,' has sold more than 5 million copies in 29 languages, and E-Myth methodology is taught in 118 universities worldwide.

According to Gerber, the core of the E-Myth is to work on the business, not in the business, in order to create the systems that allow ordinary people to produce extraordinary results, over and over again. The systems then allow the business to be continually improved through innovation, quantification and orchestration.

Gerber’s experience will contribute significantly to the ReliantHeart Board of Directors, as the company advances its revolutionary HeartAssist5® VAD, a powerful, implantable, electric pump designed to augment a failing human heart.

The HeartAssist5® has been proven effective in supporting blood circulation, reversing end-organ dysfunction and giving patients a much-improved quality of life as they await heart transplants. More than 12,000 patients worldwide have been supported by ventricular assist devices while awaiting transplant, however, the HeartAssist5® is the only VAD in the world that allows healthcare providers to monitor their patients remotely.

The HeartAssist5® System is currently being implanted in certified centers across Europe. ReliantHeart intends to enter a United States FDA approved clinical trial in 2014 to collect safety and effectiveness data. For more information, visit http://www.ReliantHeart.com.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11356777.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
2. Introducing a New, Easy Way for Industrial Businesses to Join the Online Conversation
3. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
4. McGladrey Manufacturing and Distribution Monitor® Shows Business Accelerating Despite Concerns About Government Gridlock
5. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
6. Zyngenia, Inc. Promotes Chief Scientific Officer and Hires Chief Business Officer
7. Animal Husbandry Equipment Market in United States: Business Report 2011
8. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
9. InterMune to Report Unaudited Fourth Quarter Esbriet® Revenue and Business Update on January 5
10. inVentiv Health to Acquire SDI Promotional and Medical Audit Businesses From IMS Health
11. ConnectBiotech.org Launched, a Unique Life Science Business Networking Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2019)... ... October 22, 2019 , ... nQ Medical, Inc. of Cambridge, MA, was ... Companies List which was announced at a showcase event yesterday in Los Angeles. nQ ... strong business plans, and impressive near-term growth projections to be named one of the ...
(Date:10/22/2019)... ... October 22, 2019 , ... DermBiont, ... its lead program, DBI-001, met its primary safety endpoints, with no application site ... clinical trial for the treatment of interdigital tinea pedis (athlete’s foot). Additionally, the ...
(Date:10/15/2019)... , ... October 14, 2019 , ... ARPR , an award-winning tech PR agency ... honored as a Health Care Agency of the Year in the Ragan’s Health Care ... as a finalist by Ragan’s. The firm also revealed today that its healthIT practice group ...
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has added an ... 2019 in Las Vegas with spots still open. , The speaker, Dr. Ian White ... League universities including Cornell, Harvard and Dartmouth. He currently serves as the Chief Scientific ...
Breaking Biology Technology:
(Date:11/7/2019)... ... November 07, 2019 , ... R3 Stem Cell is now ... the rest of 2019. The code to use during checkout is FIFTYOFF and applies ... is the nation’s leader in regenerative therapies with over 12,000 successful stem cell procedures ...
(Date:11/5/2019)... ... November 05, 2019 , ... Catalent, ... drugs, biologics, gene therapies, and consumer health products, today announced it will present ... Barcelona, Spain on Nov. 12 – 14, 2019. , On Wednesday, Nov. 13 ...
(Date:10/30/2019)... ... October 29, 2019 , ... LGC Maine Standards ... analyzers, Order Numbers 701sa & 704sa. The kits, in a human-urine matrix, evaluate ... , Each VALIDATE® kit, liquid, ready-to-use, and prepared using the CLSI EP06-A “equal ...
Breaking Biology News(10 mins):